FY2024 EPS Estimates for Aspen Aerogels Reduced by Analyst

Aspen Aerogels, Inc. (NYSE:ASPN) – Investment analysts at Seaport Res Ptn dropped their FY2024 EPS estimates for shares of Aspen Aerogels in a report released on Monday, November 11th. Seaport Res Ptn analyst T. Curran now forecasts that the construction company will post earnings of $0.11 per share for the year, down from their prior estimate of $0.19. The consensus estimate for Aspen Aerogels’ current full-year earnings is $0.11 per share. Seaport Res Ptn also issued estimates for Aspen Aerogels’ Q4 2024 earnings at $0.09 EPS, Q1 2025 earnings at $0.06 EPS, Q2 2025 earnings at $0.16 EPS, Q3 2025 earnings at $0.19 EPS, Q4 2025 earnings at $0.19 EPS, FY2025 earnings at $0.60 EPS and FY2026 earnings at $0.83 EPS.

ASPN has been the subject of several other research reports. Roth Mkm reduced their price target on shares of Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating for the company in a research report on Friday, November 8th. Piper Sandler reduced their price target on shares of Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating for the company in a research report on Tuesday, October 22nd. StockNews.com upgraded shares of Aspen Aerogels to a “sell” rating in a research report on Wednesday. TD Cowen increased their price target on shares of Aspen Aerogels from $36.00 to $41.00 and gave the company a “buy” rating in a research report on Tuesday, August 20th. Finally, HC Wainwright restated a “buy” rating and set a $30.00 price target on shares of Aspen Aerogels in a research report on Wednesday, October 16th. One research analyst has rated the stock with a sell rating, nine have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $28.70.

Aspen Aerogels Stock Performance

NYSE ASPN opened at $14.27 on Thursday. Aspen Aerogels has a 1 year low of $9.89 and a 1 year high of $33.15. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.93 and a quick ratio of 2.82. The firm has a market cap of $1.17 billion, a price-to-earnings ratio of 1,474.47 and a beta of 2.21. The company has a fifty day moving average price of $22.23 and a 200-day moving average price of $24.60.

Insider Buying and Selling at Aspen Aerogels

In related news, CEO Donald R. Young sold 63,355 shares of the company’s stock in a transaction that occurred on Monday, September 30th. The shares were sold at an average price of $30.03, for a total value of $1,902,550.65. Following the transaction, the chief executive officer now directly owns 483,640 shares in the company, valued at approximately $14,523,709.20. This represents a 11.58 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Ricardo C. Rodriguez sold 32,465 shares of the company’s stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $30.14, for a total transaction of $978,495.10. Following the completion of the transaction, the chief financial officer now owns 20,790 shares in the company, valued at approximately $626,610.60. This trade represents a 60.96 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 4.30% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the business. BNP Paribas Financial Markets lifted its stake in Aspen Aerogels by 85.2% in the first quarter. BNP Paribas Financial Markets now owns 25,706 shares of the construction company’s stock worth $452,000 after acquiring an additional 11,823 shares during the period. Oppenheimer & Co. Inc. bought a new stake in shares of Aspen Aerogels during the 1st quarter valued at about $388,000. Swiss National Bank grew its stake in shares of Aspen Aerogels by 16.2% during the 1st quarter. Swiss National Bank now owns 120,500 shares of the construction company’s stock valued at $2,121,000 after purchasing an additional 16,800 shares during the period. Vanguard Group Inc. grew its stake in shares of Aspen Aerogels by 5.1% during the 1st quarter. Vanguard Group Inc. now owns 3,619,702 shares of the construction company’s stock valued at $63,707,000 after purchasing an additional 175,906 shares during the period. Finally, Healthcare of Ontario Pension Plan Trust Fund purchased a new position in shares of Aspen Aerogels during the 1st quarter valued at about $851,000. 97.64% of the stock is currently owned by institutional investors.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.